Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

In an email, the company pointed out that the majority of patients in LITESPARK-005 received Welireg as their third or fourth-line treatment (87.4%) after being treated with PD-1/L1 inhibitor and ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...

--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the first single-use reactor specifically designed to manufacture antibody ...

Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as HARMONi-2. Last June, Summit Therapeutics created a lot of buzz — and sent its stock surging ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

SAN JOSE, Calif. , Sept. 11, 2024 /PRNewswire/ -- Upstage today announced the release of a preview version of its next-generation large language model (LLM), Solar Pro. This preview, available as ...

RAHWAY, N.J., September 10, 2024 – Merck Manuals, an authoritative online medical reference, shares advice from experts on when telehealth helps support access to healthcare and positive healthcare ...

Solar Pro is the most intelligent LLM optimized to run on a single GPU, outperforming models from tech giants like Microsoft, Meta, and Google. SAN JOSE, Calif. , Sept. 11, 2024 /PRNewswire/ -- ...